RxDoctor Payments Data

Julie Henne-Reese

Family · Queenstown, MDNPI 1669473948

Payments from drug & device makers

$1,669in general payments, 2019–2025

Across 103 payments — averaging $16.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$519
  • GSK$268
  • Lilly USA, LLC$101
  • AbbVie$72
  • Pfizer$71
  • Amgen$69
  • plus $568 from 17 others

What the payments were for

  • Food & beverage$1,669100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,669 in reported general payments places this provider in the 80th percentile of 2,843 family providers in Maryland.

See all family providers in Maryland

Medicare billing

Part B allowed, 2024
$132,008
Medicare patients
157
Services billed
1,539

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin46$33,946
EliquisApixaban41$23,295
AbrysvoRsv Vacc, Pref A And Pref B/Pf28$8,478
JanuviaSitagliptin Phosphate13$7,716
TrintellixVortioxetine Hydrobromide13$6,467
Atorvastatin Calcium190$2,484
Carbidopa-LevodopaCarbidopa/Levodopa26$2,180
Levothyroxine Sodium200$2,090
Lantus SolostarInsulin Glargine,hum.Rec.Anlog24$1,906
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst81$1,893
Celecoxib25$1,615
Raloxifene Hcl25$1,529
Tamsulosin Hcl76$1,501
Famotidine106$1,493
Pantoprazole Sodium99$1,452

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$61$33,94646 claims
PfizerEliquis, Abrysvo$71$31,77369 claims
MerckJanuvia$67$7,71613 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$36$6,46713 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$17$2,090200 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,843 family providers in Maryland.

Other family in Queenstown

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →